Pulmonary Lymphangiomyomatosis Responsive to Progesterone
about
Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosisResponse to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.Primary abdominal lymphangioleiomyomatosis: report of a case.Tuberous sclerosis with pulmonary involvementLymphangioleiomyomatosis: what do we know and what are we looking for?Lymphangioleiomyomatosis presenting in a postmenopausal woman.Pulmonary tuberous sclerosis treated with tamoxifen and progesterone.Pulmonary manifestations of tuberous sclerosis in first degree relatives.Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study.Lymphangiomyomatosis: a respiratory illness with an endocrinologic therapy.Recurrent chylothorax in a woman with primary amenorrhoea.The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.Tuberous sclerosis complex: Recent advances in manifestations and therapy.Longitudinal follow-up study of 11 patients with pulmonary lymphangioleiomyomatosis: diverse clinical courses of LAM allow some patients to be treated without anti-hormone therapy.Early onset of childhood pulmonary lymphangiomyomatosis.Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment.
P2860
Q34204852-35BF0683-9498-4580-A8B4-D8FE4C6EE43DQ34745513-8323BF6E-96C9-4E33-BB13-87B8A11AF8E3Q35164925-6720AE29-B82F-4B0C-B4E5-ED7FE71724C0Q35806081-BDAD6037-4821-4C37-9B2E-72C79B38A76EQ36067383-0E160BB4-EEA0-45CF-A976-B417C54236C7Q36146804-2459F9C6-7125-430F-BF0F-BBC861ECBDB5Q36160267-9F255A26-7E92-43F8-8011-BDE7896596F9Q36198311-3C0749F2-50B0-4025-BB91-6EDC9B0245DCQ36575291-631A81A9-9B81-47D4-B27D-6F3C196D97E0Q36646872-11F48F2D-CADD-4706-90F0-15E9E0837F29Q36679239-73B7C2D6-2FAF-4682-BC22-5AAD6D6024B1Q37144539-D4194CD8-E964-4FC5-A991-CF2F29E3CF52Q39408346-1E3283A6-EA66-4E32-831A-21CA0294480EQ43885833-C674C79F-DD84-4A4C-9FF1-33939D9A88A6Q46077882-E4AA00A6-3397-4254-82B2-6A8E501B6641Q48355779-BC4B544E-6BEA-4065-A8E8-3ED5B1DD9F1CQ50650281-89F28950-F00B-464C-8337-6675329D2670
P2860
Pulmonary Lymphangiomyomatosis Responsive to Progesterone
description
article
@en
im Dezember 1980 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1980
@uk
ലേഖനം
@ml
name
Pulmonary Lymphangiomyomatosis Responsive to Progesterone
@en
Pulmonary Lymphangiomyomatosis Responsive to Progesterone
@nl
type
label
Pulmonary Lymphangiomyomatosis Responsive to Progesterone
@en
Pulmonary Lymphangiomyomatosis Responsive to Progesterone
@nl
prefLabel
Pulmonary Lymphangiomyomatosis Responsive to Progesterone
@en
Pulmonary Lymphangiomyomatosis Responsive to Progesterone
@nl
P2093
P1476
Pulmonary Lymphangiomyomatosis Responsive to Progesterone
@en
P2093
Herbert O. Sieker
Jeffrey A. Mossler
Kenneth S. McCarty
Robert McLelland
P304
P356
10.1056/NEJM198012183032506
P407
P577
1980-12-18T00:00:00Z